SAN FRANCISCO, May 30, 2016 /PRNewswire/ --
The global parenteral nutrition market is
expected to reach USD 7.3 billion by
2024, according to a new report by Grand View Research, Inc. The
increasing natality rate, the growing malnutrition coupled with the
prevalence of chronic conditions such as cancer and
gastro-intestinal tract diseases are expected to boost the market
over the forecast period.
(Logo:
http://photos.prnewswire.com/prnh/20150105/723757 )
The presence of malnourished children in the developing
countries leading to the rise in the natality rate and the rising
geriatric population suffering from a deficiency of essential
nutrients are some of the major factors that are expected to fuel
the global parenteral nutrition market.
According to the WHO around 40.0% patients across the world were
malnourished in 2010. The study also indicated that about one-third
of the patients in Europe were
malnourished in 2012, thereby fueling industry growth.
According to the statistics provided by the World Bank Group,
India had the highest natality
rate followed by China in 2012.
Moreover, a consistent increase in the rate of natality was
observed in the European countries such as the U.K. and
France. Therefore, Asia Pacific and Europe are expected to witness the fastest
growth over the forecast.
North America is expected to
witness lucrative growth due to the increase in consumer awareness
paired with the increasing healthcare costs. As parenteral
nutrition products are available in the home health care sector, it
further facilitates the market growth due to the increasing trend
in home health care. The increasing incidence of heart diseases is
another vital driver. According to the WHO around 49.0% of the
American population is endangered with the risk of cardiac
arrest.
Browse full research report with TOC on
"Parenteral Nutrition Market Analysis, By Nutrition Type
(Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid
Solution, Trace Elements, Vitamins and Minerals) And Segment
Forecasts To 2024" at:
http://www.grandviewresearch.com/industry-analysis/parenteral-nutrition-market
Further key findings from the study suggest:
- North America is expected to
dominate the overall market with a revenue share of about40.0% in
2024, owing to the increasing incidences of heart diseases coupled
with the rise in home health care.
- Asia Pacific and Europe are anticipated to be the fastest
growing region with a CAGR of over5.5% over the forecast period.
The rise in the natality rate, rising geriatric population and the
growing awareness regarding the importance of nutritional value and
its impact on health are the vital impact rendering drivers for the
region.
- Key players of the industry include Baxter International, Inc.,
Hospira, Inc., B. Braun Melsungen AG, Grifols International S.A.,
Fresenius Kabi AG, Otsuka Pharmaceutical Factory, Inc., Actavis,
Inc., Sichuan Kelun Pharmaceutical Co., Ltd. Most of these
companies have been in the business for over a decade and are
bringing in expertise and technological advancements that are
expected to help them sustain over the forecast period.
Grand View Research has segmented parenteral nutrition market
on the basis of type of nutrition and region
- Global Parenteral Nutrition Type of nutrition Outlook
(Revenue, USD Billion, 2013 - 2024)
- Carbohydrates
- Parenteral lipid emulsion
- Single dose amino acid solution
- Trace elements
- Vitamins and minerals
- Parenteral Nutrition Regional Outlook (Revenue, USD Billion,
2013 - 2024)
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
- South Africa
- Saudi Arabia
Browse related reports by Grand View
Research:
- Orthobiological Products Market -
http://www.grandviewresearch.com/industry-analysis/orthobiological-products-market
- Active Pharmaceutical Ingredient (API) Market -
http://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market
- Bone Morphogenetic Proteins (BMP) Market -
http://www.grandviewresearch.com/industry-analysis/bone-morphogenetic-proteins-market
- Biotechnology Reagents Market -
http://www.grandviewresearch.com/industry-analysis/biotechnology-reagent-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company
provides syndicated research reports, customized research reports,
and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant
and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Read Our Blogs - legalworkshop.org,
grandviewresearch.com/blogs/healthcare
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: http://www.grandviewresearch.com